Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant.
OBJECTIVE
To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis.


METHODS
Case report.


RESULTS
A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up.


CONCLUSIONS
Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.
Seth
Rajeev K
RK
Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Gaudio
Paul A
PA
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002833:Choroiditis / Q000188:drug therapy* / Q000473:pathology*; D004343:Drug Implants; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage* / Q000627:therapeutic use; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D007267:Injections; D008875:Middle Aged; D016896:Treatment Outcome; D014822:Vitreous Body
D000893:Anti-Inflammatory Agents; D004343:Drug Implants; D005446:Fluocinolone Acetonide